Follow the latest coverage, related explainers and connected technology stories.
Austin-based Tiny Health raised $33 million in a Series B round led by B Capital to expand its at-home microbiome testing and partnerships with healthcare providers. The company plans to use the funding to develop its TinyAI tool and fund research testing whether changes in the microbiome actually improve health outcomes.
The U.S. Food and Drug Administration has authorized Vitestro’s Aletta, a robotic system that uses imaging, ultrasound, and artificial intelligence to draw blood samples without direct manual intervention by a specialist throughout the procedure. The device may allow one specialist to supervise up to three devices at a time, as the United States faces a shortage of workers trained in blood collection.